TEST FÜR IN-VITRO-TOXIZITÄTSSCREENING
European patent · EP3394258 · In force
Register entry
- Publication number
- EP3394258
- Application number
- EP16784871
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Oct 19, 2016
- Published
- Oct 31, 2018
- Granted
- Sep 22, 2021
- Protection ends at the latest
- Oct 18, 2036
- Next annual fee due
- Oct 31, 2026
- IPC classes
- C12N 15/11 (2006.01)
- Priority
- EP 15191075 22.10.2015EP 15191076 22.10.2015WO PCT/EP2015/076967 18.11.2015EP 15195198 18.11.2015WO PCT/EP2015/076971 18.11.2015EP 15195202 18.11.2015WO PCT/EP2015/079915 16.12.2015EP 16161820 23.03.2016EP 16174974 17.06.2016
- PCT application
- PCT/EP2016/075060 19.10.2016
- PCT publication
- WO2017/067970 27.04.2017
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Nov 1, 2025
Change
Published in Swissreg on 01.11.2025
- Feb 21, 2025
Holder’s address changed
- Owner
- Roche Innovation Center Copenhagen A/S, Fremtidsvej 3, 2970 Hørsholm, Denmark → RICC A/S, c/o Roche Diagnostics A/S, Flaskehalsen 17, 4., 1799 Kobenhavn V, Denmark
Published in Swissreg on 21.02.2025
- Nov 1, 2024
Change
Published in Swissreg on 01.11.2024
- Nov 1, 2023
Change
Published in Swissreg on 01.11.2023
- Nov 1, 2022
Change
Published in Swissreg on 01.11.2022
- Aug 3, 2022
Change
Published in Swissreg on 03.08.2022
- Sep 22, 2021
Granted
Published in Swissreg on 22.09.2021
Parties
Inventor
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.